HMGCS2 and type 2 diabetes mellitus: Analysis of the rate-limiting ketogenic enzyme HMGCS2 revealed significantly elevated expression in T2DM-NAFLD cohorts compared to NAFLD controls during the early stages of the disease (weeks 0–4).